Transcatheter treatment of tricuspid valve

Massimo Chessa, Luca Giugno, Gianfranco Butera, Mario Carminati

Research output: Chapter in Book/Report/Conference proceedingChapter


Tricuspid valve replacement is not a common operation and, in most series, is associated with high postoperative mortality. Although bioprosthetic valves appear to have improved the performance early after surgery, these valves will inevitably experience wear and degeneration, requiring a second implant. Redo valve surgery for bioprosthetic valve failure is challenging. In this context, there has been an understandable interest in percutaneous valve therapy to extend the life span of failing tricuspid valve prostheses. We briefly discuss in this chapter some technical issues and the first results of these new techniques of implant of orthotopic and heterotopic tricuspid valve. A long-term follow-up and large series are needed to improve these percutaneous approaches, but they are other weapons in the hands of the cardiologist to treat many patients with important co-morbidities, heart failure and high risk for surgical repair.

Original languageEnglish
Title of host publicationThe Tricuspid Valve in Congenital Heart Disease
PublisherSpringer-Verlag Italia s.r.l.
Number of pages9
ISBN (Print)9788847054004, 8847053994, 9788847053991
Publication statusPublished - Feb 1 2014

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Transcatheter treatment of tricuspid valve'. Together they form a unique fingerprint.

Cite this